COVID-19 vaccine booster shots will be widely available to the American public, starting next month, according to a joint statement today from Biden administration health officials. The booster program, for recipients of the Pfizer and Moderna mRNA vaccines, will begin the week of Sept. 20 for individuals who are eight months removed from their second COVID-19 vaccine dose. The plan is contingent on a Food and Drug Administration review of data for third doses of the mRNA vaccines, alongside the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices issuing booster dose recommendations based on a thorough review of the evidence.

At this time the booster program does not apply to individuals who received the Johnson & Johnson COVID-19 vaccine, a program that began later than that of Pfizer and Moderna and thus lacks data to support an informed decision on boosters’ necessity.

Meanwhile, the Biden administration is expected in September to issue emergency regulations requiring nursing homes, as a condition of Medicare and Medicaid participation, fully vaccinate their staff. The requirement would apply to more than 15,000 facilities and their 1.3 million health care workers.
 

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…